Literature DB >> 18657952

Premorbid functioning of patients with first-episode nonaffective psychosis: a comparison of deterioration in academic and social performance, and clinical correlates of Premorbid Adjustment Scale scores.

Ralph C Monte1, Sandra M Goulding, Michael T Compton.   

Abstract

BACKGROUND: Motivated by a previous study among male veterans [Allen, D.N., Frantom, L.V., Strauss, G.P., van Kammen, D.P., 2005. Differential patterns of premorbid academic and social deterioration in patients with schizophrenia. Schizophr. Res. 75, 389-397], the present analysis examined: (1) patterns of premorbid academic and social functioning during childhood, early adolescence, and late adolescence, and (2) associations between these premorbid functioning dimensions and a number of clinical variables.
METHODS: Data on premorbid functioning were collected using the Premorbid Adjustment Scale (PAS) in 95 hospitalized first-episode patients. Analyses were similar to those conducted by Allen and colleagues (2005).
RESULTS: Deterioration was evident in both academic and social functioning from childhood to early adolescence, along with a pronounced/accelerated deterioration in academic functioning from early adolescence to late adolescence, occurring in both male and female patients. Age at onset of prodromal symptoms was predicted by childhood/early adolescent/late adolescent academic functioning scores, and age at onset of psychotic symptoms was significantly associated only with childhood academic functioning. Severity of negative symptoms was predicted by childhood and late adolescent social functioning scores, and severity of general psychopathology symptoms was predicted by late adolescent academic functioning, as well as childhood and late adolescent social functioning scores.
CONCLUSIONS: Consistent with prior findings, deterioration in premorbid functioning appears to be more pronounced in the academic than social dimension of the PAS. Some PAS scores are predictive of ages at onset of prodrome/psychosis and severity of psychotic symptoms. Ongoing research on premorbid adjustment in schizophrenia may have implications for future prevention goals.

Entities:  

Mesh:

Year:  2008        PMID: 18657952      PMCID: PMC2603279          DOI: 10.1016/j.schres.2008.06.009

Source DB:  PubMed          Journal:  Schizophr Res        ISSN: 0920-9964            Impact factor:   4.939


  22 in total

1.  Confirmation of a two-factor model of premorbid adjustment in males with schizophrenia.

Authors:  D N Allen; M E Kelley; R K Miyatake; J A Gurklis; D P van Kammen
Journal:  Schizophr Bull       Date:  2001       Impact factor: 9.306

2.  Dimensions of premorbid functioning in schizophrenia: a review of neuromotor, cognitive, social, and behavioral domains.

Authors:  Lindsay S Schenkel; Steven M Silverstein
Journal:  Genet Soc Gen Psychol Monogr       Date:  2004-08

3.  Premorbid functioning and treatment response in recent-onset schizophrenia.

Authors:  Jonathan Rabinowitz; Philip D Harvey; Marielle Eerdekens; Michael Davidson
Journal:  Br J Psychiatry       Date:  2006-07       Impact factor: 9.319

4.  Patterns of premorbid functioning in first episode psychosis: relationship to 2-year outcome.

Authors:  J Addington; D Addington
Journal:  Acta Psychiatr Scand       Date:  2005-07       Impact factor: 6.392

5.  Differential patterns of premorbid academic and social deterioration in patients with schizophrenia.

Authors:  Daniel N Allen; Linda V Frantom; Gregory P Strauss; Daniel P van Kammen
Journal:  Schizophr Res       Date:  2005-01-05       Impact factor: 4.939

6.  Premorbid social functioning in schizophrenia and bipolar disorder: similarities and differences.

Authors:  M Cannon; P Jones; C Gilvarry; L Rifkin; K McKenzie; A Foerster; R M Murray
Journal:  Am J Psychiatry       Date:  1997-11       Impact factor: 18.112

7.  Characterizing and dating the onset of symptoms in psychotic illness: the Symptom Onset in Schizophrenia (SOS) inventory.

Authors:  D O Perkins; J Leserman; L F Jarskog; K Graham; J Kazmer; J A Lieberman
Journal:  Schizophr Res       Date:  2000-07-07       Impact factor: 4.939

8.  Reliability and validity of the premorbid adjustment scale (PAS) in a German sample of schizophrenic and schizoaffective patients.

Authors:  H Krauss; K Marwinski; T Held; M Rietschel; H J Freyberger
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  1998       Impact factor: 5.270

9.  Premorbid adjustment as predictor of outcome in schizophrenia: results of a prospective study.

Authors:  J Bailer; W Bräuer; E R Rey
Journal:  Acta Psychiatr Scand       Date:  1996-05       Impact factor: 6.392

10.  Premorbid adjustment as a predictor of phenomenological and neurobiological indices in schizophrenia.

Authors:  S Gupta; R Rajaprabhakaran; S Arndt; M Flaum; N C Andreasen
Journal:  Schizophr Res       Date:  1995-08-15       Impact factor: 4.939

View more
  20 in total

1.  Pre-illness cannabis use and the early course of nonaffective psychotic disorders: associations with premorbid functioning, the prodrome, and mode of onset of psychosis.

Authors:  Michael T Compton; Beth Broussard; Claire E Ramsay; Tarianna Stewart
Journal:  Schizophr Res       Date:  2010-10-30       Impact factor: 4.939

2.  Using Digital Technology in the Treatment of Schizophrenia.

Authors:  Michelle H Lim; David L Penn
Journal:  Schizophr Bull       Date:  2018-08-20       Impact factor: 9.306

3.  Potentially important periods of change in the development of social and role functioning in youth at clinical high risk for psychosis.

Authors:  Eva Velthorst; Jamie Zinberg; Jean Addington; Kristin S Cadenhead; Tyrone D Cannon; Ricardo E Carrión; Andrea Auther; Barbara A Cornblatt; Thomas H McGlashan; Daniel H Mathalon; Diana O Perkins; Larry J Seidman; Ming T Tsuang; Elaine F Walker; Scott W Woods; Abraham Reichenberg; Carrie E Bearden
Journal:  Dev Psychopathol       Date:  2017-04-19

4.  Overview and initial validation of two detailed, multidimensional, retrospective measures of substance use: the Lifetime Substance Use Recall (LSUR) and Longitudinal Substance Use Recall for 12 Weeks (LSUR-12) Instruments.

Authors:  Claire E Ramsay; Glen R Abedi; John D Marson; Michael T Compton
Journal:  J Psychiatr Res       Date:  2010-05-20       Impact factor: 4.791

5.  Trajectories of premorbid childhood and adolescent functioning in schizophrenia-spectrum psychoses: A first-episode study.

Authors:  Leslie E Horton; Sarah I Tarbox; Thomas M Olino; Gretchen L Haas
Journal:  Psychiatry Res       Date:  2015-03-02       Impact factor: 3.222

6.  Demographic and socioenvironmental predictors of premorbid marijuana use among patients with first-episode psychosis.

Authors:  Luca Pauselli; Michael L Birnbaum; Beatriz Paulina Vázquez Jaime; Enrico Paolini; Mary E Kelley; Beth Broussard; Michael T Compton
Journal:  Schizophr Res       Date:  2018-02-04       Impact factor: 4.939

7.  Differences in developmental changes in academic and social premorbid adjustment between males and females with schizophrenia.

Authors:  Daniel N Allen; Gregory P Strauss; Kimberly A Barchard; Mary Vertinski; William T Carpenter; Robert W Buchanan
Journal:  Schizophr Res       Date:  2013-03-13       Impact factor: 4.939

8.  Prevalence and correlates of school drop-out prior to initial treatment of nonaffective psychosis: further evidence suggesting a need for supported education.

Authors:  Sandra M Goulding; Victoria H Chien; Michael T Compton
Journal:  Schizophr Res       Date:  2009-09-24       Impact factor: 4.939

9.  Subtyping first-episode non-affective psychosis using four early-course features: potentially useful prognostic information at initial presentation.

Authors:  Michael T Compton; Mary E Kelley; Dawn F Ionescu
Journal:  Early Interv Psychiatry       Date:  2013-01-24       Impact factor: 2.732

10.  Reading deficits in schizophrenia and individuals at high clinical risk: relationship to sensory function, course of illness, and psychosocial outcome.

Authors:  Nadine Revheim; Cheryl M Corcoran; Elisa Dias; Esther Hellmann; Antigona Martinez; Pamela D Butler; Jonathan M Lehrfeld; Joanna DiCostanzo; Jennifer Albert; Daniel C Javitt
Journal:  Am J Psychiatry       Date:  2014-09       Impact factor: 18.112

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.